These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 7839061

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Failure of vinorelbine to produce responses in pretreated non-small cell lung cancer patients.
    Pronzato P, Landucci M, Vaira F, Vigani A, Bertelli G.
    Anticancer Res; 1994; 14(3B):1413-5. PubMed ID: 8067715
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Adynamic ileus in a patient with non-small-cell lung cancer after treatment with vinorelbine.
    Liebmann J, Friedman K.
    Am J Med; 1996 Dec; 101(6):658-9. PubMed ID: 9003116
    [No Abstract] [Full Text] [Related]

  • 7. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis.
    Le Chevalier T, Pujol JL, Douillard JY, Alberola V, Monnier A, Riviere A, Lianes P, Chomy P, Cigolari S, Besson F.
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
    Masters GA, Hoffman PC, Drinkard LC, Watson S, Samuels BL, Golomb HM, Vokes EE.
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [The incidence of phlebitis in the patients administrated vinorelbine by intravenous bolus injection--a retrospective study].
    Nakayama S, Matsubara N, Sakai T, Aso N.
    Gan To Kagaku Ryoho; 2002 Apr; 29(4):633-5. PubMed ID: 11977554
    [No Abstract] [Full Text] [Related]

  • 15. Randomized study of maintenance vinorelbine in responders with advanced non-small-cell lung cancer.
    Westeel V, Quoix E, Moro-Sibilot D, Mercier M, Breton JL, Debieuvre D, Richard P, Haller MA, Milleron B, Herman D, Level MC, Lebas FX, Puyraveau M, Depierre A, French Thoracic Oncology Collaborative Group (GCOT).
    J Natl Cancer Inst; 2005 Apr 06; 97(7):499-506. PubMed ID: 15812075
    [Abstract] [Full Text] [Related]

  • 16. Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer.
    Souquet PJ, Fournel P, Bohas CH, Fortune IC, Chatte G.
    Semin Oncol; 1996 Apr 06; 23(2 Suppl 5):8-10. PubMed ID: 8610239
    [Abstract] [Full Text] [Related]

  • 17. Vinorelbine--a clinical review.
    Gregory RK, Smith IE.
    Br J Cancer; 2000 Jun 06; 82(12):1907-13. PubMed ID: 10864196
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cost-effectiveness analysis of three regimens using vinorelbine (Navelbine) for non-small cell lung cancer.
    Hillner BE, Smith TJ.
    Semin Oncol; 1996 Apr 06; 23(2 Suppl 5):25-30. PubMed ID: 8610234
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.